Multi-scale characterization of tumor-draining lymph nodes in resectable lung cancer treated with neoadjuvant immune checkpoint inhibitors.

24 , 25 , 52 , 53 Concerning the metabolic activity, in contrast with the primary tumor beds, we observed an increasing trend in the SUVmax value after neoadjuvant ICIs ( Figure 2 b), which was independent of the degree of pathologic response in the matched primary tumor beds.

also in 63,971 other papers